T. Rowe Price International Stock Fund Class R (RRITX) is an open-end mutual fund that seeks long-term growth of capital primarily through investments in common stocks of established, non-U.S. companies. The fund focuses on large-cap growth stocks in the foreign large growth category, with approximately 90.86% allocated to non-U.S. equities; key sectors include technology (21.26%), industrials (16.42%), financial services (14.86%), and healthcare (13.97%); top holdings feature Taiwan Semiconductor Manufacturing Co. Ltd. (5.21%), Prosus NV (2.04%), SAP SE (1.98%), Canadian National Railway Co. (1.90%), and MercadoLibre Inc. (1.80%), comprising 12.93% of the portfolio. It provides daily pricing in USD, with a net expense ratio of 1.40%, minimum initial investment of $2,500, and is available for sale in the United States.
Launched on September 30, 2002, the fund operates under T. Rowe Price Group, Inc., a global investment management firm headquartered in Baltimore, Maryland, which manages over $1.6 trillion in assets and serves clients across 47 countries through 16 international offices. Managed by Richard Clattenburg since April 1, 2015, the fund maintains total net assets of approximately $13.94 billion, with the R class holding $17.79 million.
In recent developments, T. Rowe Price Group, the fund's parent, acquired Oak Hill Advisors for $7.5 billion in early 2025 to bolster its private credit capabilities and expand alternative investment offerings for wealth and retail clients, including potential integration with funds like RRITX. Additionally, in September 2025, the firm partnered with Goldman Sachs, which invested up to $1 billion in T. Rowe Price stock to jointly develop and distribute private-market products to retail investors, enhancing distribution channels amid a strategic push into ETFs and international retirement markets. These moves reflect T. Rowe Price's broader inorganic growth strategy while the fund continues to emphasize diversified international equity exposure across regions such as the Eurozone (22.31%), emerging Asia (15.32%), Japan (14.12%), and Canada (10.04%).